跳至主要内容
临床试验/NCT03045458
NCT03045458已完成不适用

Associations of Alveolar Bone Loss, Clinical Parameters and Interleukin-1β Levels in One and Two Stage Surgical Procedures: A Randomized Prospective Trial

Firat University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2010年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
change of alveolar bone level

研究概览

简要总结

The present study was compared the level of alveolar bone loss, clinical parameters and IL-1β in PICF in one- or two-stage surgical procedures. Half of the patients were performed tissue level implant while other half were performed bone level implant.

详细描述

The present study included 40 healthy patients (24 males and 16 females; mean age, 30.75 ± 8.58 years) who had one tooth absent in the mandible, at the Department of Periodontology, Dicle University, Diyarbakir, Turkey, between 2010 and 2011. All patients were informed in detail about the study protocol, and they were asked to sign informed consent forms. Ethics committee approval was obtained from Dicle University Ethics Committee for this study (D.Ü.D.F.E.K.2010/02)

This study was designed as a prospective, randomized, controlled study. Randomization was performed prior to surgery by opening a sequentially numbered sealed envelope corresponding to the patient recruitment number. Investigators received randomization instructions only after enrolling a subject and immediately prior to surgery. The participants were randomly divided into two groups. A one-stage surgical procedure was performed on 20 patients (Group I) and a two-stage surgical procedure was performed on the other 20 patients (Group II). The primary outcome of the study was a change in alveolar bone level at the implant site between T0 and T2 months after surgery measured on CBCT. The secondary outcomes between T0, T1, and T2 were changes the level of IL-1β PICF, probing pocket depth (PPD), modified plaque index (mPI), modified gingival index (mGI), and modified bleeding index (mBI). All implants (Straumann AG, Waldenburg, Switzerland) were inserted by the same periodontist (T.T.Y.) in the present study. Pre-surgical radiographic evaluation was conducted using CBCT. Before surgery, the patient's mouth was rinsed with chlorhexidine mouthwash. After local anesthesia, full thickness flaps were reflected, and osteotomies were prepared in the first mandibular molar sites. In these surgical operations, 20 tissue-level and 20 bone-level dental implants 12 mm in length and 4.8 mm in diameter were inserted in Group I and Group II, respectively. Three months later, second-stage surgery was performed and implant exposed into the oral cavity. Cover screw was removed and replaced with healing abutments. Three months waited for second surgery in bone level implants. Patients of both groups were enrolled in a monthly periodontal/peri-implant maintenance program after abutments were connected in which, full mouth scaling was performed around all natural teeth and implant surfaces. Oral hygiene instructions regarding regular tooth brushing were given and patients were encouraged to floss the teeth and periimplant surfaces daily. There was no implant failed during the study and adverse event of these treatments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

盲法说明

Only the surgeon knows detail about the groups of participants. Participant, care provider,outcomes assessor have no knowledge of groups

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •patients in the study who had one tooth absent in the mandible
  • •patients in the study should be least 18 years old.

排除标准

  • •Patients in the study were the absence of the following points;
  • •poor mouth hygiene,
  • •bruxism, dental implants,
  • •chemotherapy or radiotherapy,
  • •addictions (alcohol, cigarettes, and medications),
  • •disease in the jawbones observed clinically or radiographically,
  • •pregnancy,
  • •antibiotic and/or anti-inflammatory medication use in the last three months.

研究组 & 干预措施

Tissue level dental implant

Active Comparator

Tissue level dental implants (Straumann AG, Waldenburg, Switzerland) were inserted in patients group I (n=20).

干预措施: tissue level dental implant (Device)

Bone level dental implant

Active Comparator

Bone level dental implants (Straumann AG, Waldenburg, Switzerland ) were inserted in patients group II (n=20).

干预措施: Bone level dental implant (Device)

结局指标

主要结局

change of alveolar bone level

时间窗: 0 and 6 month

The primary outcome of the study was a change in alveolar bone level (height in mm) at the 40 implant site between T0 and T2 months after surgery measured on CBCT. All measurements were performed at four sites (mesial, distal, buccal, and lingual) around each dental implant at T0 and T2. These four values were then averaged for each dental implant. * Alveolar bone level were measured in millimeters (height in mm) from a fixed reference point on the implant (implant shoulder to the most coronal position of the crestal bone contacting the implant).

次要结局

  • changes of Modified gingival index(0, 3, and 6 month)
  • changes level of IL-1β(0, 3, and 6 month)
  • changes of Modified plaque index(0, 3, and 6 month)
  • changes of PPD(0, 3, and 6 month)
  • changes of Modified bleeding index(0, 3, and 6 month)

研究者

发起方
Firat University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tuba Talo yıldırım

assistant professor

Firat University

研究点 (1)

Loading locations...

相似试验